Extract Or Material Containing Or Obtained From A Multicellular Fungus As Active Ingredient (e.g., Mushroom, Filamentous Fungus, Fungal Spore, Hyphae, Mycelium, Etc.) Patents (Class 424/195.15)
-
Patent number: 7938981Abstract: A composition for deicing or for the preparation of a heat transfer fluid is provided. The composition comprises a mixture of at least two carboxylic acid salts having a t/c ratio of 2 or lower, including a dicarboxylic salt and a monocarboxylic salt, said dicarboxylic salt being present in the mixture in an amount of at least 50 wt % of the weight of the mixture, on a dry basis. More particularly, said mixture is including a succinate and a formate, wherein the succinate is in an amount of at least 50 wt %, on a dry basis. Also provided is a method for deicing a surface or preventing the accumulation of ice, snow or a mixture thereof on a surface, comprising a step of applying on a surface covered by ice, snow or a mixture thereof, or susceptible of being covered by ice, snow or a mixture thereof, the above composition. The composition is also useful for the preparation of a heat transfer fluid coolant to be used in a heat transfer system comprising a heat transfer fluid provided with a cooling system.Type: GrantFiled: September 24, 2010Date of Patent: May 10, 2011Assignee: Bioamber S.A.S.Inventors: Dilum Dunuwila, Roger L. Bernier
-
Publication number: 20110104251Abstract: The present invention comprises cosmetic compositions and methods for retarding hair growth comprising a combination of an ornithine decarboxylase inhibitor, an anti-angiogenic active and an anti-inflammatory.Type: ApplicationFiled: May 25, 2010Publication date: May 5, 2011Inventors: Mindy S. Goldstein, Chia Wen Chen, Christina G. Fthenakis, Kenneth D. Marenus, Thomas Mammone
-
Publication number: 20110097356Abstract: Disclosed herein is a cosmetic composition which can inhibit skin aging resulting from external harmful environmental factors such as UV light and environmental pollution, which promote aging. More specifically, disclosed is a cosmetic composition, which contains green tea polysaccharide and Tricholoma matsutake extract and shows an excellent anti-aging effect by inhibiting skin inflammatory and oxidative processes.Type: ApplicationFiled: February 4, 2010Publication date: April 28, 2011Inventors: Chan Koo KANG, Sung A. Cho, Ji Hyun Kim, Hui Kyoung Chang, Nok Hyun Park, Jun Cheol Cho
-
Publication number: 20110091579Abstract: An filamentous fungi is disclosed with a naturally vitamin D enriched nutritional profile. These enriched mushrooms were shown to have a synergistic effect on longevity of subjects with both a normal and nutritionally deficient diets, improved tolerance to oxidative stress, and increased longevity in a Alzheimer's disease model. Surprisingly, vitamin D2 and D3 fed alone or in combination with nonenriched mushrooms did not produce similar effects.Type: ApplicationFiled: September 21, 2010Publication date: April 21, 2011Applicant: TOTAL NUTRACEUTICAL SOLUTIONS, INC.Inventor: MARVIN S. HAUSMAN
-
Publication number: 20110086105Abstract: Described herein are methods for identifying novel nucleic acid regulatory elements and compounds that modulate the regulation of such elements. Also described herein are nucleic acid sequence identified as novel nucleic acid regulatory elements and host cells containing such nucleic acid regulatory elements in a vector.Type: ApplicationFiled: May 17, 2010Publication date: April 14, 2011Inventors: Anthony Giordano, Paul S. Eder, Deborah Beach McGill, Gregg Johannes
-
Patent number: 7923044Abstract: A dietary supplement composition having an ORAC value in excess of at least about 2,500 and which can be readily consumed in a small quantity is provided for supplementing an individual's daily intake. The dietary supplement composition suitably includes organic and/or vegan ingredients and can be consumed in quantities of as little as about 1 tablespoon to provide an amount of antioxidants equivalent to at least the minimum recommended daily intake of five to nine servings of fruits and/or vegetables.Type: GrantFiled: July 15, 2009Date of Patent: April 12, 2011Assignee: Paradise Herbs & Essentials, Inc.Inventor: Scott Bias
-
Patent number: 7919102Abstract: Basidiomycetes which is a novel mushroom having an excellent immunopotentiating action, etc., a Basidiomycetes extract composition, and health foods and immunopotentiators using the Basidiomycetes extract composition are provided. Basidiomycetes has no basidium forming potential. In particular, Basidiomycetes is Basidiomycetes-X FERM BP-10011. A Basidiomycetes extract composition is extracted from them with an extraction solvent including at least one solvent selected from water and a hydrophilic solvent.Type: GrantFiled: February 12, 2009Date of Patent: April 5, 2011Assignee: Mycology Techno. Corp.Inventor: Tetsuo Watanabe
-
Publication number: 20110076303Abstract: An objective of the present invention is to provide an anti-graying agent. The present invention provides a method for screening an anti-graying agent whereby a substance that increases expression of AFF-4 in cells is selected by applying a candidate substance to cells in vitro; and, an anti-graying agent containing at least one type of herbal extract selected from the group consisting of Ganoderma lucidum (Fr.) Karst. extract, Panax schinseng Nees extract, Oryza sativa (Rice) Bran extract and Rabdosia japonicus extract selected with this method in an amount effective for increasing expression of AFF-4.Type: ApplicationFiled: June 25, 2010Publication date: March 31, 2011Inventors: Tokuro Iwabuchi, Lorin Weiner, Janice Brissette, Jian Li
-
Publication number: 20110059123Abstract: The present invention relates to a novel application of a compound. The compound 4-hydroxy-2,3-dimethoxy-6-methyl-5-(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone of the invention is isolated and purified from the extracts of Antrodia camphorata, which can be applied for inhibiting the survival of colorectal cancer cells and be used as a pharmaceutical composition to inhibit the colorectal tumor growth.Type: ApplicationFiled: September 7, 2010Publication date: March 10, 2011Applicant: GOLDEN BIOTECHNOLOGY CORPORATIONInventors: Sheng-Yun Liu, Wu-Che Wen, Mao-Tien Kuo
-
Publication number: 20110059124Abstract: This invention discloses a kind of quality control method and application of Ganoderma lucidium spore oil fat emulsion. Which includes Ganoderma lucidium spore oil 2˜25%, emulsifier 0.5˜10%, isosmotic agent 0.2˜5%, the remaining content is water and the final pH of Fat emulsion is adjusted to 6˜9. The quality control method of this invention can accurately determine the content of 1,2-oleic-3-palmitic triglyceride and glycerol trioleate in the preparation, and accurately determine the ergosterol content, which serves as the method and basis for quality control of this product. Fingerprints are utilized to grasp the product quality from the overall characteristics of Chromatogram. This invention has clearly defined active ingredients, with excellent bioactivity, and is capable of tumor treatment, while improving the organism's immunity, as well as the life quality of tumor patients undergoing radiotherapy and chemotherapy, and relieving the drug toxicity after treatment.Type: ApplicationFiled: February 26, 2008Publication date: March 10, 2011Applicant: Guangzhou Hanfang Natural Medicine Research & Development Co.LtdInventors: Lulin Chen, Fahuan Ge, Wenjun Chen, Ronghua Zeng, Genghai Meng, Aishao Zhang, Qingshui Lai, Zhaojian Jiang
-
Inhibition of the Survival of Oral Cavity Cancer by Cyclohexenone Compounds from Antrodia Camphorata
Publication number: 20110059122Abstract: The present invention relates to a novel application of a compound. The compound 4-hydroxy-2,3-dimethoxy-6-methyl-5-(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone of the invention is isolated and purified from the extracts of Antrodia camphorata, which can be applied for inhibiting the survival of oral cavity cancer cells and be used as a pharmaceutical composition to inhibit the oral cavity tumor growth.Type: ApplicationFiled: September 7, 2010Publication date: March 10, 2011Applicant: GOLDEN BIOTECHNOLOGY CORPORATIONInventors: Sheng-Yun Liu, Wu-Che Wen, Mao-Tien Kuo -
Publication number: 20110052718Abstract: Phytoceutical compositions for the prevention and treatment of circulatory disorders, feminine endocrine disorders, and dermal disorders. A specific combination of extracts of plants is taught, as well as principles for varying the formulations based on categorizing plants into one of three groups, Energy, Bio-Intelligence, and Organization and selecting several plants from each group. Such combinations have synergistic effects, with minimal side effects.Type: ApplicationFiled: November 9, 2010Publication date: March 3, 2011Inventor: José Angel Olalde Rangel
-
Publication number: 20110052622Abstract: The present disclosure provides medicinally active extracts and fractions, and methods for using the same to increase eukaryotic cell adhesion, to increase differentiation of eukaryotic cells to produce increased numbers of immature dendritic cells, to enhance or accelerate condrogenesis of MSCs, to maintain undifferentiated CD34+ hematopoietic stem cells, and to inhibit or reduce the blood EPCs formation and angiogenic potential. These methods are useful for modulating immune response, modulating hematopoietic activity, inhibiting tumor angiogenesis, and engineering certain types of eukaryotic tissues.Type: ApplicationFiled: August 25, 2009Publication date: March 3, 2011Inventors: Chi-Huey Wong, Daniel Tzu-Bi Shih, Wan-Yu Chen
-
Patent number: 7897154Abstract: Dermal drops that, when applied topically to animal subjects, can ameliorate symptoms of conditions such as diabetes and Parkinson's disease are prepared as concentrates of the culture filtrate of a Basidiomycete fungus grown under appropriate conditions. The concentrate can also be used as a convenient source of liquid compost factor.Type: GrantFiled: August 9, 2007Date of Patent: March 1, 2011Assignee: ABR, LLCInventor: Bryan Hiromoto
-
Publication number: 20110033556Abstract: A natural pharmaceutical preparation for treating hypoproteinemia, includes at least one member selected from the group consisting of a drug of increasing human serum albium, a drug of improving and enhance immunity, a drug of treating hepatitis B, a drug of treating Hepatitis C, a drug of treating acquired immune deficiency syndrome (AIDS), a drug of treating Tuberculosis, a drug of treat Fibrosis, a drug of treating hydrothorax, a drug of easing pain, a drug of stopping diarrhea, a drug of arresting coughing, a drug of reducing inflammation, and a drug of increasing urine.Type: ApplicationFiled: June 4, 2010Publication date: February 10, 2011Inventors: Zheming Jin, Xitian Zhang
-
Patent number: 7883708Abstract: A novel substance that has the physiological activity of the aglycone of isoflavones and the physiological activity of the culture of the basidiomycetes with the physiological activities being synergistically enhanced, obtained by cultivating a basidiomycetes having a ?-glucosidase activity in a medium containing an isoflavone, a method for producing it, and food, feedstuff and medicine containing it. The substance of the invention is improved in the physiological effect of the aglycone of isoflavones and the physiological effect of the culture of the basidiomycetes, and is not only useful as an anti-tumor agent but also is useful for therapy and/or prevention of osteoporosis and also as an immune enhancement agent.Type: GrantFiled: April 24, 2008Date of Patent: February 8, 2011Assignee: Amino Up Chemical Co., Ltd.Inventors: Ken-ichi Kosuna, Lan Yuan, Takehito Miura, Buxiang Sun
-
Publication number: 20110027305Abstract: Provided is a composition for treating and preventing diabetes or diabetic complications comprising an extract of herbal combination as an effective ingredient. The composition for treating and preventing diabetes or diabetic complications includes an extract of herbal combination of bitter melon, caterpillar fungus, wolfberry tree bark, white mulberry bark, winged euonymus, kudzu root, Solomon's seal, white atractylodes rhizome, mondo grass rhizome, Japanese cornel fruit and ginseng as an effective ingredient. The composition increases secretion of insulin in a type 2 diabetic animal, improves insulin resistance and exhibits potent blood sugar-lowering and diabetic complication inhibiting activities. Further, since it is safe with natural product ingredients, it may be usefully used to prevent and improve diabetic diseases and inhibit diabetic complications.Type: ApplicationFiled: August 2, 2010Publication date: February 3, 2011Applicant: DAI HAN PHARM. DO., LTD.Inventor: Sung Young Lee
-
Publication number: 20110008384Abstract: Compounds having unique antiviral properties are prepared from medicinal mushroom mycelium, extracts and derivatives. The compositions are derived from Fomitopsis and blends of medicinal mushroom species and are useful in preventing and treating viruses including Poxviridae and Orthopox viruses.Type: ApplicationFiled: March 27, 2007Publication date: January 13, 2011Inventor: Paul Edward Stamets
-
Patent number: 7862822Abstract: The present invention relates to topical skin whitening compositions comprising a whitening effective amount of a black yeast-derived melanin-degrading enzyme extract and a method of preparing the compositions. The compositions provide a whitening effect by degrading melanin on the surface of the skin, the hair and the nails. The enzyme extract can be derived from Exophiala mansonii. The compositions containing the enzyme extract are more effective than are similar compositions containing kojic acid in producing a whitening effect on the skin.Type: GrantFiled: September 25, 2007Date of Patent: January 4, 2011Assignee: ELC Management LLCInventors: Thomas Mammone, Neelam Muizzuddin, Steven F. Schnittger
-
Publication number: 20100322961Abstract: The present invention provides an intranasal drug delivery system containing capsaicin, dihydrocapsaicin, nordihydrocapsaicin, homodihydrocapsaicin, and homocapsaicin in the form of oleoresin capsicum used as a carrier to quickly and effectively deliver a drug.Type: ApplicationFiled: August 3, 2010Publication date: December 23, 2010Inventor: Wayne Jeffrey Perry
-
Publication number: 20100322960Abstract: A Ganoderma tsugae active substance, produced from Ganoderma tsugae by following steps: (1) liquid culturing Ganoderma tsugae; (2) extracting the fermentation filtrate obtained with ethanol to obtain ethanol extraction precipitate; (3) purifying the ethanol extraction precipitate obtained by gel filtration chromatography to obtain gel filtration chromatographed product; and (4) extracting the gel filtration chromatographed product obtained with acetone to obtain the supernatant as the desired Ganoderma tsugae active substance.Type: ApplicationFiled: June 22, 2009Publication date: December 23, 2010Applicant: Syngen Biotech Co., Ltd.Inventors: Yu-Shan Wei, Chia-Wen Hsieh, Being-Sun Wung
-
Patent number: 7854936Abstract: Methods and compositions for reducing and/or inhibiting inflammation by topical application of dermatocosmetic compositions comprising effective amounts of extracts of Coriolus versicolor that have been hydrolyzed by an acid protease, preferably Rhizomucor miehei, and thereafter rendered substantially devoid of acid-protease activity.Type: GrantFiled: January 14, 2008Date of Patent: December 21, 2010Assignee: Active Organics, Inc.Inventors: Michael Bishop, Elysiann Bishop, Walter Smith, Glen Gillis
-
Patent number: 7854935Abstract: The present invention provides herbal formulas, and compositions thereof, that can treat or reduce the severity, intensity, or duration of asthma and asthma-related symptoms. The compositions may optionally include one or more adjuvants, cytokines, encapsulating materials, or pharmaceutically acceptable carriers or excipients, and may be administered prior to, during, or after the development of asthmatic symptoms in a patient in need thereof.Type: GrantFiled: March 14, 2005Date of Patent: December 21, 2010Assignee: Herbal Spring, LLCInventors: Xiu-Min Li, Hugh A. Sampson, Ming-Chun Weng
-
Publication number: 20100310598Abstract: Topical compositions comprising extracts of Rhizomucor miehei that are substantially devoid of acid-protease activity and their use in treating dermatologic conditions, including reducing the appearance of signs of skin aging.Type: ApplicationFiled: June 3, 2010Publication date: December 9, 2010Applicant: ACTIVE ORGANICS, LPInventors: Michael Bishop, Elysiann Bishop, Glen Gillis
-
Publication number: 20100291154Abstract: Disclosed is a composition for the inhibition of transplant rejection and the prevention and treatment of skin diseases, comprising a cordyceps mycellia extract as an active ingredient. The cordyceps mycellia extract significantly suppresses the production of antibodies to transplants without side effects, such as weight change. Based on natural material, the composition is non-toxic and harmless to the human body and thus can be used as an immunosuppressant for organ transplantation. Also, it stops oozing from sores and is useful in the prevention and treatment of skin diseases, including atopy, allergic reactions, decubitus ulcers, pemphigus and smallpox.Type: ApplicationFiled: December 7, 2007Publication date: November 18, 2010Applicant: HANKOOK PHARM. CO., INC.Inventors: Man Woo Han, Jae Kuk Yoo, Chang-Uk Hur, Hwan-Chul Kim, Jin Pyo Kim
-
Publication number: 20100291135Abstract: The present invention describes substantially pure cultures of three new species of fungi, Meira geulakonigae (CBS 110052), Meira argovae (CBS 110053) and Acaromyces ingoldii (CBS 110050) (all nom. prow.), wherein said cultures are biologically pure. The conditioned medium for all three new fungi species is also described, as well as their biologically active products. The biological product of the three new fungi species and their conditioned medium has miticidal and fungicidal activities. Thus, a composition for the control of mites and/or phytopathogenic fungi comprising a biocontrol agent derived from any one of the three new fungi species is also described, optionally comprising an agriculturally compatible carrier. Finally, the present invention describes a method for producing a fungicide and/or a miticide, wherein the active ingredient of said fungicide/miticide is any one of M. geulakonigae, M. argovae, or A.Type: ApplicationFiled: April 22, 2010Publication date: November 18, 2010Inventors: Abraham Sztejnberg, Uri Gerson, Aviva Gafni
-
Publication number: 20100285053Abstract: The present invention described herein relates to aqueous extracts of Cordyceps sinensis for use as an immunosuppressant agent.Type: ApplicationFiled: June 11, 2007Publication date: November 11, 2010Applicant: Dalhousie UniversityInventors: Timothy Dominic Gerard Lee, Julie Lynn Jordan
-
Publication number: 20100285054Abstract: The present invention is directed to a fungal extract comprising antimicrobial activity. More specifically, the fungus used belongs to the family Polyporaceae, especially genus Trametes, namely Trametes sp. 11 E4. Specifically, the extract demonstrated activity against bacteria such as R. sonalacearum, E. coli, S. aureus, B. cereus and S. anatum. It also may be used in compositions, such as pest control compositions, which would be useful in agriculture, i.e. treating bacterial wilt and medicine.Type: ApplicationFiled: December 28, 2007Publication date: November 11, 2010Inventors: Helenires Queiroz De Souza, Luiz Antonio De Oliveira
-
Patent number: 7829098Abstract: Methods for preparing an herbal powder extract from a polysaccharide-peptide rich mushroom, including Coriolus versicolor (Yunzhi), are disclosed. A more effective, highly pure Yunzhi powder extract, methods of preparing and using the same in ameliorating cancerous cell proliferations and hepatitis and are also disclosed.Type: GrantFiled: November 8, 2005Date of Patent: November 9, 2010Assignee: Vita Green Health Products Co., LtdInventors: Helen Hei Ling Chan, Clara Bik San Lau, Moses Sing Sum Chow
-
Publication number: 20100278855Abstract: The subject invention provides methods for treatment of degenerative neurological disorders such as Parkinson's disease and Alzheimer's disease comprising administration of a Ganoderma lucidum extract. The subject invention also provides a method for inhibiting the activation of microglial cells by applying the Ganoderma lucidum extract to the cells.Type: ApplicationFiled: April 29, 2010Publication date: November 4, 2010Inventors: BILL PIU CHAN, RUIPING ZHANG
-
Publication number: 20100275329Abstract: Mushrooms genetically engineered to produce provitamin A carotenoids including ?-carotene, ?-carotene, ?-carotene, and ?-cryptoxanthin are provided. In some embodiments, mushrooms are transformed with genes that encode enzymes that have phytoene synthase, pyhtoene dehydrogenase and lycopene cyclase activities and function to convert GGPP to one or more provitamin A carotenoids. Mushrooms are transformed using known methods, including Agrobacterium-mediated transformation. Transgenic mushrooms producing provitamin A carotenoids are useful to treat, alleviate, reduce, and/or inhibit one or more symptoms of a disease or disorder associated with vitamin A deficiency (VAD).Type: ApplicationFiled: February 11, 2010Publication date: October 28, 2010Inventor: VORANADDHA VACHARATHIT
-
Patent number: 7820175Abstract: The present invention provides herbal formulas, and compositions thereof, that can treat or reduce the severity, intensity, or duration of food allergy and food allergy related symptoms. The compositions may optionally include one or more adjuvants, cytokines, encapsulating materials, or pharmaceutically acceptable carriers or excipients, and may be administered prior to, during, or after the development of food allergy-related symptoms in a patient in need thereof.Type: GrantFiled: March 14, 2005Date of Patent: October 26, 2010Assignee: Herbal Spring, LLCInventors: Xiu-Min Li, Hugh A. Sampson
-
Publication number: 20100255024Abstract: Disclosed is a composition for the inhibition of transplant rejection and the prevention and treatment of skin diseases, comprising a Phellinus sp. mycelial extract as an active ingredient. The Phellinus sp. mycelial extract significantly suppresses the production of antibodies to transplants without side effects, such as weight change. Based on natural material, the composition is non-toxic and harmless to the human body and thus can be used as an immunosuppressant for organ transplantation. Also, it stops oozing from sores and is applicable to the prevention and treatment of skin diseases, including atopy, allergic reactions, decubitus ulcers, and smallpox.Type: ApplicationFiled: December 7, 2007Publication date: October 7, 2010Applicant: HANKOOK PHARM. CO., INC.Inventors: Man Woo Han, Jae Kuk Yoo, Chang-Uk Hur, Hwan-Chul Kim, Jin Pyo Kim
-
Publication number: 20100239602Abstract: This invention is intended to discover a fraction having strong anti-influenza virus activity via M? activation in the Grifola frondosa extract or an active substance distributed therein to develop a simple and effective production method and to use such fraction for food and beverage products, pharmaceutical products, feeds or feed additives, and the like. This is realized by treatment of maitake mushrooms with a molecular sieve apparatus, such as an ultrafiltration apparatus or gel filtration apparatus, to isolate glycoprotein-containing fractions or sugar-protein complex-containing fractions having molecular weights of 30,000 to 100,000, so as to minimize the influence on substances having strong anti-influenza virus activity and contaminants.Type: ApplicationFiled: October 26, 2007Publication date: September 23, 2010Applicant: YUKIGUNI MAITAKE CO., LTD.Inventors: Masataka Watanabe, Masahide Takeyama
-
Publication number: 20100226935Abstract: Methods of defining a standard for a traditional medicine are provided. A method can comprise obtaining at least two samples of the traditional medicine that have been authenticated by qualitative profiling as representing a control positive; quantitatively profiling each of the at least two samples using at least two physicochemical analyses; blending the at least two samples to form the standard; and creating a quantitative profile for the standard using at least two physicochemical analyses, wherein the quantitative profile for the standard defines the standard. Methods of certifying a test sample of a traditional medicine are also provided. A method can comprise creating a quantitative profile for the test sample using at least two physicochemical analyses; providing a standard; and comparing the quantitative profile for the standard to the quantitative profile for the test sample. A certified traditional medicine comprises a traditional medicine certified by these methods.Type: ApplicationFiled: September 12, 2008Publication date: September 9, 2010Inventors: Albert Y. Leung, Greg Pennyroyal
-
Publication number: 20100226936Abstract: A composition for affecting one or more of influenza, inflammation, and immune system function, said composition comprising an extract prepared from Radix isatidis and an extract prepared from Flos Lonicerae. In alternative embodiments, the composition further comprises one or more of an extract prepared from Poria cocos(Schw.) Wolf and an extract prepared from Herba houttuyniae. Method for treating one or more of influenza, inflammation by administering a patient a therapeutically effective amount of the above composition.Type: ApplicationFiled: March 2, 2010Publication date: September 9, 2010Applicant: VIVA PHARMACEUTICAL INC.Inventors: Xueju XIE, Jason Jiang-Chung KO
-
Patent number: 7790175Abstract: The present invention provides a new strain of turkey tail mushroom (Trametes versicolor (L.: Fr.) Pilat) having excellent biological activities (Accession number: FERM BP-10633). The strain is excellent in platelet aggregation inhibitory effect, chemokine gene expression inhibitory effect, antimutagenic effect, antitumor effect, antihypertensive effect, and immunomodulatory effect. The effect of the strain is enhanced synergistically by combining with microalgae and other basidiomycetes. The turkey tail mushroom of the present invention has high safety, and a possibility that a side effect is caused because of long-term continuous use is very low. Thus, it is useful for food/drink, cosmetics, pharmaceuticals or the like, the objective of which is the prevention and improvement in inflammation, allergy, tumor, and other diseases.Type: GrantFiled: July 28, 2006Date of Patent: September 7, 2010Assignee: Nikken Sohonsha CorporationInventors: Fumio Eguchi, Ryo Sumi, Nobuo Mori
-
Patent number: 7790176Abstract: The present invention generally relates to the use of a formula that improves human and animal endurance, stamina, performance and other physical parameters. In one composition aspect, the formula or composition of the present invention includes a Flammulina velutipes extract and citrus peel.Type: GrantFiled: May 27, 2008Date of Patent: September 7, 2010Assignee: Botanica BioScience CorporationInventor: Edward Stephen Morrissey
-
Patent number: 7785600Abstract: A method for treating an allergy by providing a pharmaceutical composition containing at least Ganoderma lucidum extract and administering a therapeutically effective amount of the composition to a patient in need thereof. Also disclosed is a method for treating an allergy by first purifying Ganoderma lucidum extract into at least one fraction, then providing a pharmaceutical composition comprising at least one of the Ganoderma lucidum fractions, and administering a therapeutically effective amount of the composition to a patient in need thereof. A method for alleviating symptoms of an allergy is disclosed. The symptoms of the allergy are alleviated by providing a pharmaceutical composition containing at least Ganoderma lucidum extract and administering an amount of the composition effective to decrease at least one of an IgE and IgG2a level, whereby the symptoms of the allergy are ameliorated.Type: GrantFiled: August 29, 2008Date of Patent: August 31, 2010Assignees: Wyntek Corporation, Academia SinicaInventors: Tseng-Rong Tu, Chia-Feng Li, Sung-Hsieh Su, Chi-Huey Wong, Eugene Fan
-
Publication number: 20100215687Abstract: A food or pharmaceutical agent is provided for treating or offsetting the risks of a disease or disorder such as a cardiovascular disease, a hypercholesterolemia disorder, a low serum high density lipid (HDL)/low density lipid (LDL) ratio, a hypertriglyceridemia disorder, and diabetes includes a pharmaceutical carrier, and a composition including a purified glucomannan and at least one galactomannan. A method for treating or offsetting the risks of such a disease or disorder includes the step of administering to a human in need thereof an effective amount of the pharmaceutical composition to treat the cardiovascular disease.Type: ApplicationFiled: April 12, 2010Publication date: August 26, 2010Applicant: MANNATECH, INCORPORATEDInventor: Robert A. Sinnott
-
Patent number: 7781193Abstract: The present invention provides a method for extracting lipids from microorganisms without using organic solvent as an extraction solvent. In particular, the present invention provides a method for extracting lipids from microorganisms by lysing cells and removing water soluble compound and/or materials by washing the lysed cell mixtures with aqueous washing solutions until a substantially non-emulsified lipid is obtained.Type: GrantFiled: July 24, 2007Date of Patent: August 24, 2010Assignee: Martek Biosciences CorporationInventors: Craig M. Ruecker, Swithwin Patrick Adu-peasah, Brian S. Engelhardt, George T. Veeder, III
-
Patent number: 7776339Abstract: Topical compositions comprising extracts of Rhizomucor miehei that are substantially devoid of acid-protease activity and their use in treating dermatologic conditions, including reducing the appearance of signs of skin aging.Type: GrantFiled: January 11, 2006Date of Patent: August 17, 2010Assignee: Active Organics, LPInventors: Michael Bishop, Elysiann Bishop, Glen Gillis
-
Publication number: 20100203077Abstract: Compositions for treating skin containing at least one extract from the genus Trametes and at least one viscosity enhancing synthetic polymer, and methods for whitening skin, treating skin for improvement, or treating skin disorders associated with pigmentation such as uneven pigmentation, skin mottling, or age spots or other dermatological disorders such as eczema, rosacea, hyperkeratinization, and so on.Type: ApplicationFiled: November 21, 2008Publication date: August 12, 2010Inventors: Steven F. Schnittger, Daniel H. Maes, Michael Sullivan
-
Patent number: 7771759Abstract: Disclosed herein is a natural oriental medicinal composition for the promotion of hair growth. The oriental medicinal composition comprises a black bean extract, a tangerine extract, a potato extract, a pine needle extract and a quartzite powder. Since the oriental medicinal composition comprises crude drugs extracted from natural substances that can prevent hair loss, it is effective for hair growth and has ensured biostability. Particularly, the oriental medicinal composition allows newborn hair to grow in the form of stiff hair.Type: GrantFiled: March 21, 2007Date of Patent: August 10, 2010Inventor: Hyeong Geun Choi
-
Publication number: 20100196443Abstract: A dietary supplement or animal feed includes at least one Cordyceps species or extract thereof. The dietary supplement and/or animal feed is preferably for oviparous animals and in particular for the production of eggs.Type: ApplicationFiled: July 4, 2008Publication date: August 5, 2010Applicant: A P NUTRIPHARM PTE. LTD.Inventor: Yue Xu
-
Publication number: 20100196496Abstract: There are provided various compounds and compositions comprising polyunsaturated fatty acid monoglycerides and derivatives thereof. These compounds and compositions can be useful as cancer chemopreventive agents. They can also be useful for enhancing solubility of various active agents and enhancing their bioavailability.Type: ApplicationFiled: August 6, 2009Publication date: August 5, 2010Inventor: Samuel FORTIN
-
Publication number: 20100183526Abstract: The present invention relates to a method for obtaining a cosmetic product from a tiger nut milk concentrate, characterized in that it comprises: a) mixing in a tank sugar-free tiger nut milk with cosmetic ingredients and thermal deionized distilled water; b) mixing in a second tank surfactants with molasses alcohol; c) mixing the products resulting from the previous steps in order to produce a base concentrate; d) applying ultrasounds to said base concentrate; and f) adding pharmaceutically acceptable excipients, as well as to the base concentrate, and to the cosmetic product resulting from said method.Type: ApplicationFiled: July 24, 2008Publication date: July 22, 2010Inventors: Daniel Tortajada Forner, Jose Antonio Novejarque Conde
-
Publication number: 20100183660Abstract: A composition comprising Chinese herbal medicines Ramulus cinnamoni and Poria cocos is provided, wherein the composition is defined by a fingerprint profile obtained from an improved chromatographic method. Various uses of such compositions are also provided.Type: ApplicationFiled: October 17, 2007Publication date: July 22, 2010Inventors: Wei Xiao, Xiang Ling Dai, Ya Ling, Zhen Zhong Wang, Yu An Bi, Zheng Kuan Wang
-
Patent number: 7758878Abstract: A cosmetic treatment system is provided having ingredients that may prevent signs of aging, improve the aesthetic appearance of skin, and promote recovery from environmental stresses. The composition includes natural ingredients, including at least one ingredient or extract from rosemary; at least one ingredient or extract from Centella, Echinacea, Alpinia or mixtures thereof; a DNA repair enzyme; and at least one pharmaceutically or cosmetically acceptable vehicle. The treatment system may further include a patch for applying the cosmetic ingredients and/or a packaging system for holding the components of the cosmetic treatment system.Type: GrantFiled: April 5, 2007Date of Patent: July 20, 2010Assignee: Access Business Group International LLCInventors: John V. Scimeca, Amy C. Zimmerman, Mark F. Mettler, Akiko Kudo, Yoko Kawasaki
-
Publication number: 20100178286Abstract: A dietary supplement composition comprising a therapeutically effective amount of at least one sirt 1 activating agent, a therapeutically effective amount of at least one Qi activating agent, and an therapeutically effective amount of at least one adaptogen is disclosed. An optional herbal treatment for stress-related deep wrinkles comprises chronic oral administration for at least two weeks of a beverage containing an effective amount of a valerian root extract sufficient to provide a desired reduction in the appearance of the deep wrinkles. A photoprotective agent may also be included. Also included are a microcirculation increasing agent. Also optional are an herbal toner and topical cellulite product.Type: ApplicationFiled: January 4, 2010Publication date: July 15, 2010Inventor: Walter P. Smith